China Consumers Association Wins Lawsuit Over Falsely Advertised Disinfection Card

What changed

China’s consumer watchdog has won its first court-judged public-interest lawsuit over the portable “北方清晨” air-disinfection card.

The Shandong High People’s Court ordered three companies to stop producing and selling it. Producer Shunfeng Gene Technology must pay consumers more than 2 million yuan in triple compensation; distributors Qingdao Zhongkeruiye Gene Biotechnology and Zhongcheng Northern Biomedical each carry joint liability up to more than 1.06 million yuan.

Testing found core sterilisation results in the 50%-60% range, far below the advertised 99.99%. The product was also falsely presented as developed by the Chinese People’s Liberation Army General Hospital.

Why it matters

The ruling turns a cheap online product into a costly legal warning. A claim that sounded reassuring on a shopping page now carries a production ban, a large penalty and liability reaching beyond the manufacturer to two distributors.

That matters because individual buyers faced a lopsided fight. Each purchase may have involved a relatively small loss, while proving that a disinfection product failed its advertised purpose required testing and technical evidence. The lawsuit allowed those scattered complaints to be handled as a public-interest case instead of leaving each consumer to pursue the matter alone.

The court’s finding also targets more than an inflated number. The product borrowed the name of a trusted hospital, giving a weak claim the appearance of institutional authority. Informed speculation suggests that this combination of fear-based advertising and borrowed credibility will draw closer scrutiny wherever online products promise protection against health risks.

The case is part of a wider legal effort: since consumer-protection law clarified the role of consumer associations in 2014, the China Consumers Association and 21 provincial consumer associations have filed 182 public-interest lawsuits, with their core claims supported. This first court victory gives that enforcement route a concrete result: stop the product, compensate buyers and make the companies behind the listing share the consequences.